McCord JL, Tsuchimochi H, Kaufman MP. P2X2/3 and P2X3 receptors contribute to the metaboreceptor component of the exercise pressor reflex. J Appl Physiol 109: 1416-1423, 2010. First published August 26, 2010 doi:10.1152/japplphysiol.00774.2010The exercise pressor reflex is due to activation of thin fiber afferents within contracting muscle. These afferents are in part stimulated by ATP activation of purinergic 2X (P2X) receptors during contraction. Which of the P2X receptors contribute to the reflex is unknown; however, P2X2/3 and P2X3 receptor subtypes are good candidates because they are located on thin fiber afferents and are involved in sensory neurotransmission. To determine if P2X2/3 and P2X3 receptors evoke the metabolic component of the exercise pressor reflex, we examined the effect of two P2X2/3 and P2X3 antagonists, A-317491 (10 mg/kg) and RO-3 (10 mg/kg), on the pressor response to injections of ␣,␤-methylene ATP (␣,␤-MeATP; 50 g/kg), freely perfused static contraction, contraction of the triceps surae muscles while the circulation was occluded, and postcontraction circulatory occlusion in decerebrate cats. We found that the antagonists reduced the pressor response to ␣,␤-MeATP injection (before ⌬ 20 Ϯ 3 mmHg; drug ⌬ 11 Ϯ 3 mmHg; P Ͻ 0.05), suggesting the antagonists were effective in blocking P2X2/3 and P2X3 receptors. P2X2/3 and P2X3 receptor blockade reduced the pressor response to freely perfused contraction (before ⌬ 33 Ϯ 5 mmHg; drug ⌬ 15 Ϯ 5 mmHg; P Ͻ 0.05), contraction with the circulation occluded (before ⌬ 52 Ϯ 7 mmHg; drug ⌬ 20 Ϯ 4 mmHg; P Ͻ 0.05), and during postcontraction circulatory occlusion (before ⌬ 15 Ϯ 1 mmHg; drug ⌬ 5 Ϯ 1 mmHg; P Ͻ 0.05). Our findings suggest that P2X2/3 and P2X3 receptors contribute to the metabolic component of the exercise pressor reflex in decerebrate cats.
THE EXERCISE PRESSOR REFLEX is evoked by muscle contraction and results in increased arterial pressure, heart rate, and ventilation. The sensory arm of the reflex is comprised of group III and IV muscle afferents. The former are thinly myelinated and are thought to be primarily mechanically sensitive whereas the latter are unmyelinated and thought to be primarily metabolically sensitive (4, 16, 27) . Even though several by-products of contraction are thought to be involved in stimulating metaboreceptors, the exact mechanism of the metabolic component of the exercise pressor reflex has not been elucidated.
Several lines of evidence suggest that ATP, working through purinergic 2X (P2X) receptors, is one of the substances that evokes the metabolic component of the exercise pressor reflex. For example, contraction increased ATP concentrations in the muscle interstitium of rats and cats (23, 24) . Furthermore, ATP injected into the arterial supply of skeletal muscle reflexly increased arterial pressure, heart rate, and ventilation in decerebrate cats (12) ; moreover ATP increased the discharge rate of group IV muscle afferents in rats (31) . Last, blockade of P2 receptors with PPADS decreased the exercise pressor reflex; this blockade also decreased the responses of group III and IV muscle afferents to static contraction in decerebrate cats (10, 18 -20) .
There are several P2X receptor subtypes that ATP could be activating to evoke the exercise pressor reflex. PPADS has been used to show that ATP is involved in the reflex (18 -20) . Nevertheless, PPADS blocks all P2X receptors as well as the P2Y1 receptor (9) , making it unclear which receptor subtype(s) is responsible for evoking the reflex. However, arterial injections of UTP, a selective P2Y receptor agonist, did not cause a reflex pressor response (12) , a finding that prompted us to focus on the role played by P2X receptor subtypes. We became interested in P2X2/3 and P2X3 receptors as these two subtypes are located on the peripheral and central endings of group III and IV afferents, have been shown to mediate sensory neurotransmission, and are involved in transmitting pain (6, 9, 15, 17, 21) . In addition, recent advances in understanding P2X2/3 and P2X3 receptor pharmacology have enabled the development of selective antagonists (9, 15) .
Thus the present study is our effort to determine if P2X2/3 and P2X3 receptors on thin fiber muscle afferents play a role in evoking the metabolic component of the exercise pressor reflex. The reflex effect evoked by metaboreceptors was isolated from that evoked by mechanoreceptors by measuring the arterial pressure response during postcontraction circulatory occlusion, a maneuver in which the muscle is no longer active (i.e., absence of mechanoreceptor activation) but the metabolites released during exercise are trapped within the muscle vasculature (1).
We used two structurally different P2X2/3 and P2X3 receptor antagonists, A-317491 and RO-3 (9, 15) , to determine the effect of P2X2/3 and P2X3 receptor blockade on the pressor responses to static contraction while the working muscle was freely perfused, static contraction while the circulation to the working muscle was occluded, and during postcontraction circulatory occlusion in decerebrate cats. We tested the hypothesis that P2X2/3 and P2X3 receptors play a role in evoking the metabolic component of the exercise pressor reflex.
METHODS
All procedures were reviewed and approved by the Institutional Animal Care and Use Committee of the Pennsylvania State University, Hershey Medical Center.
Surgical Preparation
Adult female cats (n ϭ 27, 2.8 Ϯ 0.2 kg, range 2.3-3.2 kg) were anesthetized with a mixture of 5% isoflurane and oxygen. The right jugular vein and common carotid artery were cannulated to deliver drugs and fluids as well as to measure arterial blood pressure, respectively. The carotid arterial catheter was connected to a pressure transducer (model P23 XL, Statham) to monitor blood pressure. Heart rate was calculated beat-to-beat from the arterial pressure pulse (Gould Biotach). The trachea was cannulated, and the lungs were ventilated mechanically (Harvard Apparatus). Arterial blood gases and pH were measured by an automated blood gas analyzer (model ABL-700, Radiometer). PCO 2 and arterial pH were maintained within normal range by either adjusting ventilation or intravenous administration of sodium bicarbonate (8.5%). A temperature probe was passed through the mouth to the stomach. Temperature was continuously monitored and maintained at 37-38°C by a water-perfused heating pad and a heat lamp.
The left common iliac vein and abdominal aorta were isolated and snares were placed around these vessels to trap injected drugs in the circulation of the leg (see below). In addition, the sacral artery, which perfuses the tail, was ligated. A catheter with its tip pointing toward the heart was passed into the right femoral artery. When the snare placed around the abdominal aorta was tightened, fluid injected from the right femoral arterial catheter flowed into the left external iliac artery. This was checked in every cat by injecting saline into the catheter in the right femoral artery and seeing blood exit the left external iliac artery, leaving it clear. The volume of saline needed to clear the left external iliac artery, which was usually 0.15-0.2 ml, was used to flush the drugs used in this experiment.
Following placement in a Kopf stereotaxic frame, each cat was decerebrated at the midcollicular level under isoflurane anesthesia. Dexamethasone (4 mg) was injected intravenously just before the decerebration procedure to minimize brain edema. The left common carotid artery was tied off to reduce bleeding. All neural tissue rostral to the midcollicular section was removed, and the cranial vault was filled with agar.
A laminectomy was performed to expose the lower lumbar and sacral portions of the spinal cord. The skin on the back was used to form a pool that was filled with warm (37°C) mineral oil. The dura of the cord was cut and reflected allowing visual identification of the spinal roots. The left L6, L7, and S1 ventral roots were identified and cut. The peripheral cut ends were draped over a stimulating electrode. The left calcaneal bone was cut, and its tendon was attached to a force transducer (model FT-10C, Grass) for measurement of the tension developed during static contraction of the left triceps surae muscles. The knee joint was secured to a post. Once the surgeries were completed, the anesthesia was withdrawn from the decerebrate cat, and the lungs were ventilated with room air. We waited for at least 60 min before performing the experimental protocols described below.
Experimental Protocols
We examined the effect of two structurally different but specific P2X2/3 and P2X3 receptor antagonists [A-317491 and RO-3 (9, 15)] on four maneuvers that evoked reflex pressor and cardioaccelerator responses. To do this, we ran four separate protocols. In the 1st protocol performed on 5 decerebrate cats, we statically contracted the freely perfused left triceps surae muscles; ϳ10 min after the end of the contraction, we injected ␣,␤-MeATP (50 g/kg; dissolved in saline), a P2X receptor agonist, into the right femoral artery. Both maneuvers were performed before and after P2X2/3 and P2X3 receptor blockade with A-317491 [10 mg/kg; dissolved in 0.5 ml saline (0.9% sodium chloride); Sigma-Aldrich]. In the second protocol performed on four decerebrate cats, we statically contracted the left triceps surae muscles while their circulation was occluded and maintained the occlusion for 60 s after the contraction ended. In addition, 10 min after the end of the postcontraction circulatory occlusion period, we injected ␣,␤-MeATP (50 g/kg) into the right femoral artery. Both maneuvers were performed before and after injection of A-317491 (10 mg/kg) into the right femoral artery. Static contraction is a combined mechanical and metabolic stimulus, whereas postcontraction circulatory occlusion is a metabolic stimulus. The circulation to the hindlimb was occluded for 3 min before starting the contraction. Contraction and postcontraction circulatory occlusion each lasted 60 s. The triceps surae muscles were contracted statically by electrical stimulating the L6, L7, and S1 ventral roots (40 Hz, 100 s, 2 times motor unit threshold). Baseline tension was set at 0.5-0.7 kg. Arterial blood pressure, heart rate, and tension were recorded for 60 s before, during, and after static contraction. ␣,␤-MeATP (50 g/kg) was injected into the right femoral artery catheter over ϳ10 s. Before injecting ␣,␤-MeATP into the femoral artery, we paralyzed the cat by injecting rocuronium bromide (0.5-0.7 mg/kg) intravenously. Rocuronium bromide is a short-lasting paralytic (ϳ5-10 min). A-317491 was injected into the right femoral artery catheter and trapped for 15 min before the circulatory occlusion was released and the hindlimb was freely perfused for 15 min. Static contraction and intra-arterial injection of ␣,␤-MeATP maneuvers were repeated 30 min after injection of A-317491 (10 mg/kg). A-317491 exhibits peak blockade effect at 30 min but persists for at least 5-8 h after administration in doses comparable to ours (14, 35) .
The next two protocols were identical to the ones described above except that instead of injecting A-317491, we injected RO-3, a structurally different but still specific P2X2/3 and P2X3 receptor antagonist (9, 15) . In the third protocol performed on five decerebrate cats, we statically contracted the left triceps surae muscles while they were freely perfused. Approximately 10 min after the end of the contraction, we injected ␣,␤-MeATP (50 g/kg). Both maneuvers were performed before and after P2X2/3 and P2X3 receptor blockade with RO-3 (10 mg/kg; Tocris Bioscience), which was dissolved in 1 ml DMSO (dimethyl sulfoxide; Fischer Scientific). In the fourth protocol performed on five decerebrate cats, we statically contracted the left triceps surae muscles while their circulation was occluded and maintained the occlusion for 60 s after the contraction ended. In addition, 10 min after the end of the postcontraction circulatory occlusion, we injected ␣,␤-MeATP (50 g/kg) into the right femoral artery. RO-3 was trapped in the hindlimb circulation for 10 min after which the hindlimb was freely perfused for 10 min. Thus the maneuvers were repeated ϳ20 min after injection of RO-3 into the right femoral artery. RO-3 has an in vivo plasma half-life of 25 min (8) . We originally chose a dose of RO-3 to match the concentration (10 mg/kg) used by our lab for other P2X antagonists, PPADS (83.4 mM) and A-317491 (88.4 mM). The molecular weight of RO-3 is lower than that of the other two P2X antagonists; thus a dose of 5 mg/kg would have been 82.6 mM. However, in two cats, RO-3 in a dose of 5 mg/kg did not have an effect on the pressor response to ␣,␤-MeATP injection, suggesting we needed a higher dose to block P2X2/3 and P2X3 receptors. With a dose of 10 mg/kg RO-3, we were in fact able to reduce the pressor response to ␣,␤-MeATP.
Control Protocols
Vehicle control protocol. We ran the protocol described above for freely perfused static contraction of the triceps surae muscles and ␣,␤-MeATP injection, but instead of injecting a P2X2/3 and P2X3 receptor antagonist, we injected DMSO (1 ml; Fischer Scientific) into the right femoral artery in five cats. We injected DMSO, the vehicle used for dissolving RO-3, to ensure that the pressor and cardioaccelerator responses to our maneuvers were repeatable and that any attenuation we documented in the protocols was due to the blockade of P2X2/3 and P2X3 receptors. We have previously shown that injection of saline, the vehicle for A-317491, has no effect on the pressor and cardioaccelerator responses to static contraction of the triceps surae muscles (28) .
Intravenous controls. In three cats, we injected A-317491 (10 mg/kg; dissolved in 0.5 ml 0.9% sodium chloride) and RO-3 (10 mg/kg; dissolved in 1 ml DMSO) into the jugular vein catheter to ensure that the attenuation we documented in the pressor and cardioaccelerator responses to our maneuvers was caused by blocking peripheral P2X2/3 and P2X3 receptors in the hindlimb and were not caused by blocking these receptors in the spinal cord or brain stem.
Capsaicin control. In six cats, we injected capsaicin (1-2 g) into the right femoral artery before and after either A-317491 or RO-3 injection. Our purpose was to ensure that any attenuation of the pressor responses to the maneuvers performed in our experiment were due to P2X2/3 and P2X3 receptor blockade and were not due to a deterioration in our preparation. Capsaicin activates TRPV1 channels, which are located on the endings of thin fiber afferents. Thus blocking P2X2/3 and P2X3 receptors should have no effect on the pressor response evoked by capsaicin injection.
Data analysis
There was no difference between the magnitude of the attenuated pressor responses from RO-3 and A-317491 in response to any maneuver (Table 1) ; therefore, we pooled the data for each maneuver. Mean arterial blood pressure and heart rate values were expressed as means Ϯ SE. Baseline mean arterial blood pressure and heart rate were measured immediately before a maneuver, and peak mean arterial blood pressure and heart rate were measured during injection of ␣,␤-MeATP as well as during the 60-s period of static contraction or postcontraction circulatory occlusion. The tension-time index was calculated by integrating the area between the tension trace and the baseline level (Spike 2) and is expressed in kilogram seconds (kg·s) (30) . Statistical comparisons were performed with either a one-or two-way repeated-measures ANOVA. If significant main effects were found with an ANOVA, post hoc tests were performed with the Tukey test between individual means. The criterion for statistical significance was P Ͻ 0.05.
RESULTS

Freely Perfused Contraction
In 10 cats, contraction while the muscles were freely perfused increased mean arterial pressure above baseline levels both before and after P2X2/3 and P2X3 receptor blockade (P Ͻ 0.05; Fig. 1 ). The magnitude of the pressor response to contraction, however, was attenuated by P2X2/3 and P2X3 receptor blockade (P Ͻ 0.05; Fig. 1 ). The tension-time index was not different before and after P2X2/3 and P2X3 receptor blockade (P ϭ 0.48; Table 2 ). Likewise, the pressor response to ␣,␤-MeATP injection in these 10 cats was reduced by P2X2/3 and P2X3 receptor blockade (P Ͻ 0.05; Fig. 1 ). In two cats, A-317491 was ineffective at reducing the pressor response to ␣,␤-MeATP injection and static contraction; however, in these two cats, the nonspecific P2X antagonist, PPADS, reduced the pressor to ␣,␤-MeATP injection and static contraction.
Circulatory Occluded Contraction
We found that the pressor and cardioaccelerator responses to contraction were greater when the circulation was occluded than those to contraction when the muscles were freely perfused (P Ͻ 0.05; Figs. 1 and 2 and Table 3 ). In nine cats, circulatory occluded contraction increased mean arterial pressure above baseline levels both before and after P2X2/3 and P2X3 receptor blockade (P Ͻ 0.05; Fig. 2 ). P2X2/3 and P2X3 receptor antagonists attenuated the pressor response to static contraction while the circulation was occluded (P Ͻ 0.05; Figs.  2 and 3) . To isolate metaboreceptors from mechanoreceptors, we examined the pressor response to postcontraction circulatory occlusion before and after P2X2/3 and P2X3 receptor blockade. Before blockade, the peak pressor response during postcontraction circulatory occlusion was elevated above baseline (P Ͻ 0.05; Fig. 2 ). After blockade, the pressor response during postcontraction circulatory occlusion was attenuated compared with that before blockade (P Ͻ 0.05; Figs. 2 and 3) . Heart rate was increased during circulatory occluded contraction (P Ͻ 0.05) but was not elevated above baseline during postcontraction circulatory occlusion (P ϭ 0.17; Table 3 ). The tension-time index before P2X2/3 and P2X3 receptor antagonist injection for the static contraction with the circulation occluded was not different from that after injection (P ϭ 0.86; Table 2 ). In addition, the pressor response to ␣,␤-MeATP injection in these 10 cats was reduced by P2X2/3 and P2X3 receptor blockade (P Ͻ 0.05; Fig. 2) .
Control Experiments
In each of the five cats tested, we found that the pressor responses to freely perfused contraction and ␣,␤-MeATP injection were not affected by DMSO injection (P Ͼ 0.85; Fig. 4) . The tension-time index before DMSO injection for the freely perfused static contraction was not different from that after DMSO injection (P ϭ 0.73; Table 2 ). In each of the six cats tested, P2X2/3 and P2X3 receptor blockade had no effect Table 1 on the pressor response to capsaicin injection (P ϭ 0.24; Fig. 5 ). Likewise, in each of the six cats tested, we found that intravenous injection of the P2X2/3 and P2X3 receptor antagonists had no effect on the pressor response to freely perfused static contraction or to ␣,␤-MeATP injection into the arterial supply of the hindlimb (P Ͼ 0.83; Table 4 ). We also noted that arterial injection of RO-3 (baseline: 122 Ϯ 7 mmHg; peak: 177 Ϯ 11 mmHg; ⌬: 56 Ϯ 9 mmHg; P Ͻ 0.05) and DMSO (baseline: 111 Ϯ 11 mmHg; peak: 159 Ϯ 14 mmHg; ⌬: 48 Ϯ 5 mmHg; P Ͻ 0.05) evoked large but transient pressor responses. We did not see this pressor response when A-317491 was injected (baseline: 126 Ϯ 12 mmHg; peak: 134 Ϯ 11 mmHg; ⌬: 8 Ϯ 2 mmHg; P ϭ 0.57).
. Effect of each P2X2/3 and P2X3 receptor antagonist on the MAP responses to static contraction while the muscles were freely perfused (A-317491 n ϭ 5; RO-3 n ϭ 5), to static contraction while the circulation was occluded, and postcontraction circulatory occlusion (A-317491 n ϭ 4; RO-3 n ϭ 5)
DISCUSSION
We tested the hypothesis that P2X2/3 and P2X3 receptors play a role in evoking the metabolic component of the exercise pressor reflex. We blocked P2X2/3 and P2X3 receptors by injecting two structurally different P2X2/3 and P2X3 receptor antagonists, A-317491 and RO-3, into the arterial circulation of the muscles being contracted. The efficacy of the blockade was confirmed by showing that the pressor response to arterial injection of ␣,␤-MeATP was attenuated by about half. In addition, we ensured that the attenuation of the pressor response to contraction was due to the blockade of P2X2/3 and P2X3 receptors and not to a deterioration of our preparation by finding that the pressor response was matched before and after control vehicle and capsaicin injections. We found that the pressor response to postcontraction circulatory occlusion, when only metaboreceptors were stimulated, was attenuated by P2X2/3 and P2X3 receptor blockade. This finding suggests that ATP, working through P2X2/3 and P2X3 receptors, plays a role in evoking the metabolic component of the exercise pressor reflex.
The evidence concerning ATP as a substance that evokes the exercise pressor reflex through stimulation of muscle afferents is strong. Specifically, injection of P2X agonists into the arterial supply or directly into the substance of the gastrocnemius muscle stimulated over two-thirds of the group IV afferents tested in cats (11) and rats (31) . In addition, P2X agonists injected into the arterial supply of muscle augmented the pressor response to stretch, suggesting that muscle mechanoreceptors can be sensitized by P2X receptor activation (25) . Further, blockade of P2 receptors by PPADS attenuated the responses of both group III and IV afferents to static contraction, both while the muscles were freely perfused and while they were ischemic. Likewise, PPADS attenuated the responses of group IV afferents to postcontraction circulatory occlusion (18, 20) . These findings lead us to conclude that ATP activates P2X receptors on the endings of group III and IV thin fiber afferents during exercise and that these receptors contribute to the exercise pressor reflex by sensitizing group III mechanoreceptors and stimulating group IV metaboreceptors. Our present study supports this conclusion and suggests that P2X2/3 and P2X3 receptors are in part responsible for stimulating group IV metaboreceptors during exercise. We did not test whether P2X2/3 and P2X3 receptors play a role in acti- vating mechanoreceptors but based on the above studies, we would propose that P2X2/3 and P2X3 receptors activate or at the very least sensitize group III mechanoreceptors. P2X2/3 and P2X3 receptors are not the only P2X receptors that could evoke the exercise pressor reflex. There are several P2X receptor subtypes, some of which are good candidates for investigation in the role they play in evoking the reflex. Of the P2X receptors, ␣,␤-MeATP preferentially stimulates P2X1, P2X2/3, P2X3, P2X1/5, and P2X6 receptors (15) , thus raising the possibility that any or a combination of these receptors could be involved in the exercise pressor reflex. Nevertheless, P2X1 receptors appear to be located on smooth muscle cells in the vas deferens but do not appear to be located on dorsal root ganglion cells, which were found to lack P2X1 mRNA (15, 21) . P2X6 receptors are present in the central nervous system and have also been found in skeletal muscle; however, a major function for this receptor has not been found (9) . Little is known about P2X1/5 receptors other than that they hold a combination of P2X1 and P2X5 receptor characteristics (9) . Little is also known about P2X5 receptors except that they are primarily located on skeletal muscle cells (9) . Nevertheless, recent experiments on cultured dorsal root ganglion cells using calcium imaging techniques suggested that P2X4 and P2X5 receptors are the main P2X receptor subtypes that are responsible for detecting concentrations of ATP that would be present during muscle contraction and/or pain (26) . In addition, P2X4, P2X5, and P2X6 mRNAs were found in many dorsal root ganglion neurons as were P2X2/3 and P2X3 mRNAs in rats (21) . P2X7 receptors are also involved in the sensation of pain, although the majority of these are thought to be located on macrophages and monocytes and are thought to be rare on dorsal root ganglion neurons (15, 21) . While there are specific antagonists for P2X1 and P2X7 receptors, specific antagonists for the other receptor subtypes are not yet available. Moreover, singling out the effects of P2X3 from P2X2/3 receptors is not yet possible. However, we speculate that P2X2/3 receptors might play a bigger role in eliciting the exercise pressor reflex than do P2X3 receptors because P2X2/3 receptors are more sensitive to a small pH change than are P2X3 receptors, and P2X3 receptors are quickly desensitized after activation (9, 34) . Nonetheless, as described above the possibility exists that at least one other P2X receptor subtype is involved due to our finding that in two cats, A-317491 had no effect on the pressor responses to contraction or ␣,␤-MeATP but that PPADs were in fact able to attenuate the pressor responses to the maneuvers.
ATP is not the only metabolite that has been suggested to evoke the metabolic component of the exercise pressor reflex. The pressor response to exercise can also be reduced by half by either blockade of acid sensing ion channels (ASIC), which are opened by lactic acid, or cyclooxygenase, an enzyme which results in the production of prostaglandins (28, 33) . Then how is it possible for ATP, lactic acid, and prostaglandins to be responsible for over half the reflex response? An answer to this question comes from two areas of investigation that each suggest a combination of metabolites is the key to activation of group III and IV afferents during muscular exercise. The first found that lactate and ATP together greatly potentiated the effect of an acidic pH (ϳ7.0 -6.8) on the activation of ASIC3 (13) . In addition, levels of ATP that are consistent with those released during ischemic contraction increased current through ASIC3 (29) . Lactate has a relatively quick effect on ASICs, whereas ATP needs 15-60 s after its application to exert a peak effect on ASICs; moreover, current through the channel remains high for minutes even after ATP has been removed (29) . The second area of investigation found that combinations of protons, lactate, and ATP were needed to activate cultured dorsal root ganglion cells (26) . When the cells were exposed to just one of the metabolites only a small stimulatory effect on cells was measured, whereas when the cells were exposed to a combination of the three metabolites the effect far exceeded the summation of each one individually (26) . These investigations suggest that the full expression of the exercise pressor reflex requires the synergistic interaction of at least two muscle metabolites.
We noted a pronounced pressor response when injecting RO-3 into the hindlimb vasculature, but we did not see this response when we injected A-317491. In addition, injection of DMSO, the vehicle for RO-3, also evoked a pronounced pressor response when injected into the muscular vasculature. We speculate that the pressor response came from the vehicle itself, DMSO. DMSO has been shown to cause a rapid increase in the firing rate of afferents arising from the bladder (2, 5) and the sural nerve (7) . Specifically in group III and IV bladder afferents, the initial burst of activation lasted 3-4 min and was then followed by an elevated discharge rate above baseline for ϳ30 min (5). This seems to parallel what we found when injecting RO-3 in DMSO and DMSO alone, namely a pronounced pressor response that lasted ϳ30 -60 s in 15 of 15 cats, and then arterial pressure remained above baseline in 8 of the cats for 30 min. Although the mechanism of how DMSO evokes a reflex pressor response immediately after application is unknown, DMSO has been shown to enhance nociceptive transmission in the spinal cord (2, 22) . DMSO has long been used in the medical setting as a topical analgesic, as well as in the treatment of interstitial cystitis and osteoarthritis (3, 32) . DMSO is thought to reduce pain through reducing afferent discharge. After the initial increased discharge rates of group III and IV afferents evoked by DMSO, prolonged exposure (i.e., over 30 min) to DMSO has been shown to reduce discharge rate of these afferents (7) . This finding raises the possibility that our data are due to a reduction in the ability of group III and IV afferents to respond to stimuli rather than to the blockade of P2X2/3 and P2X3 receptors. However, the attenuation of the pressor responses to ␣,␤-MeATP injection, static contraction, and postcontraction circulatory occlusion in our study appears to be due to P2X2/3 and P2X3 blockade rather than from DMSO. When DMSO was injected alone into the muscle vasculature, the pressor responses to ␣,␤-MeATP injection and static contraction were not attenuated. In addition, the pressor response to capsaicin injections was not different before or after P2X2/3 and P2X3 blockade.
In conclusion, we found that the pressor response to a freely perfused contraction was attenuated with P2X2/3 and P2X3 receptor blockade. In addition, we found that the pressor response to postcontraction circulatory occlusion, when only metaboreceptors were stimulated, was attenuated with P2X2/3 and P2X3 receptor blockade. This latter finding suggests that ATP working through P2X2/3 and P2X3 receptors is partially responsible for evoking the metabolic component of the exercise pressor reflex. However, ATP could be activating the metaboreflex through other P2X receptor subtypes and contribute to the mechanical component of the exercise pressor reflex.
